Press Release Contact

Press release:
CNBX Selects API Supplier Purisys to Support Planned IND Fillings and Phase I/II (a) Clinical Trials
November 04, 2021, 13:00 GMT

For questions about this press release, please contact the person or organization listed below.

Eyal Barad
Cannabics Pharmaceuticals Inc.
+1 877424-2429
Visit us on social media:
Facebook
X
LinkedIn
Other